Naqvi Danial, Perera Bhathika, Mitchell Sarah, Sheehan Rory, Shankar Rohit
Barnet Enfield and Haringey Mental Health Trust, UK.
Cornwall Partnership NHS Foundation Trust, UK.
BJPsych Open. 2021 Dec 6;8(1):e7. doi: 10.1192/bjo.2021.1064.
Coronavirus disease 2019 (COVID-19) has had a disproportionate impact on people with intellectual disability (PwID). PwID are at higher risk of mental illness and receive psychotropic prescribing 'off licence' also, to manage distress behaviour. The lockdown and reduction of multidisciplinary face-to-face appointments had an impact on care delivery, the recourse possibly being psychotropic prescribing. It is imperative to comprehend the influence the pandemic had on psychotropic prescribing patterns to enable future planning.
The aim was to understand the impact of the pandemic by comparing psychotropic prescribing patterns during the England lockdown with the prescribing patterns before lockdown in specialist urban and rural psychiatric services for PwID.
Data was collected from Cornwall (rural) and London (urban) intellectual disability services in England as a service evaluation project to rationalise psychotropic prescribing. PwID in both services open across January 2020 to January 2021 were included. Baseline patient demographics including age, gender, ethnicity, intellectual disability level and neurodevelopmental and psychological comorbidities were collected. Baseline psychotropic prescribing and subsequent % change for each psychotropic group for the two services was compared using Pearson's chi-square and z-statistic (two tailed) with significance taken at P < 0.05.
The two centres London (n = 113) and Cornwall (n = 97) were largely comparable but for baseline differences in terms of presence of severe mental illness (37 v. 86, P < 0.001), challenging behaviour (44 v. 57, P < 0.05) and attention-deficit hyperactivity disorder (37 v. 3, P < 0.001). There was an overall increase in psychotropic prescribing during lockdown in urban as compared with rural settings (11% v. 2%).
The pandemic caused an increase in psychotropic prescribing associated with lockdown severity and urban settings. Team structures could have played a role.
2019年冠状病毒病(COVID-19)对智障人士产生了不成比例的影响。智障人士患精神疾病的风险更高,并且还会接受“无执照”的精神药物处方,以管理困扰行为。封锁以及多学科面对面预约的减少对护理服务产生了影响,解决办法可能是开具精神药物处方。必须了解疫情对精神药物处方模式的影响,以便进行未来规划。
目的是通过比较英格兰封锁期间与封锁前针对智障人士的城市和农村专科精神科服务中的精神药物处方模式来了解疫情的影响。
作为一项使精神药物处方合理化的服务评估项目,从英格兰康沃尔郡(农村)和伦敦(城市)的智障服务机构收集数据。纳入了2020年1月至2021年1月期间开放的两个服务机构中的智障人士。收集了包括年龄、性别、种族、智障程度以及神经发育和心理合并症在内的基线患者人口统计学数据。使用Pearson卡方检验和z统计量(双侧)比较了两个服务机构中每个精神药物组的基线精神药物处方及随后的百分比变化,显著性水平设定为P<0.05。
伦敦(n = 113)和康沃尔郡(n = 97)这两个中心在很大程度上具有可比性,但在严重精神疾病的存在(37比86,P<0.001)、挑战行为(44比57, P<0.05)和注意力缺陷多动障碍(37比3, P<0.001)方面存在基线差异。与农村地区相比,城市地区在封锁期间精神药物处方总体增加(11%比2%)。
疫情导致与封锁严重程度和城市环境相关的精神药物处方增加。团队结构可能起到了一定作用。